SPDR S&P Biotech ETF $XBI Holdings Boosted by CWC Advisors LLC.

CWC Advisors LLC. grew its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,550 shares of the exchange traded fund’s stock after purchasing an additional 183 shares during the quarter. CWC Advisors LLC.’s holdings in SPDR S&P Biotech ETF were worth $460,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in XBI. Provident Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 3,000.0% during the 1st quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock valued at $25,000 after purchasing an additional 300 shares during the period. Garrison Bradford & Associates Inc. bought a new stake in SPDR S&P Biotech ETF in the first quarter valued at $39,000. Compass Wealth Management LLC lifted its stake in SPDR S&P Biotech ETF by 46.0% in the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after buying an additional 200 shares during the last quarter. Golden State Wealth Management LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after acquiring an additional 319 shares during the period. Finally, Avalon Trust Co bought a new position in shares of SPDR S&P Biotech ETF during the first quarter worth about $57,000.

SPDR S&P Biotech ETF Stock Up 3.1%

XBI stock opened at $96.68 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $105.47. The firm’s 50-day simple moving average is $89.52 and its 200 day simple moving average is $84.25. The stock has a market cap of $5.26 billion, a PE ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.